Ozempic

Public interest vs. trademark violation: How Delhi HC balanced rights to protect Dr. Reddy's trademark infringing diabetes drugs
Patient versus patent: How Indian law enables affordable medicine production without patent law violation
Ozempic dispute: Dr Reddy’s tells Delhi High Court it will rename diabetes drug from 'Olymviq' to 'Olymra'
Dr Reddy’s tells Delhi HC it will not launch oral diabetes drug within Novo Nordisk patent range
Delhi High Court asks Dr Reddy’s to halt ‘Olymviq’ sales after Novo Nordisk says it sounds like Ozempic
Ozempic drug misuse: Contempt of court plea filed in Delhi High Court against CDSCO
Delhi High Court upholds order allowing Dr Reddy’s to manufacture Ozempic-like drug for export
Delhi High Court refuses to stay order allowing Dr Reddy’s to manufacture and export Ozempic-like drug
Delhi High Court allows Sun Pharma to manufacture and export Ozempic-like drug, but no sale in India
Delhi High Court refuses to restrain Dr Reddy's from manufacturing, exporting Ozempic like drug
Delhi High Court grants interim protection from arrest to Vicky Ramancha in Ozempic scam
Delhi court denies anticipatory bail to Vicky Ramancha in US$18.8 million international Ozempic scam
Misuse of Ozempic and other diabetes drugs for weight loss: Delhi High Court directs CDSCO to respond
Bar and Bench - Indian Legal news
www.barandbench.com